Navigation Links
Mayo Clinic Alzheimer's researcher honored twice in a month
Date:5/23/2012

ROCHESTER, Minn. -- At Mayo Clinic, the name Clifford Jack Jr., M.D., means cutting-edge imaging and Alzheimer's research. This month, he was honored for his accomplishments in both areas by two different organizations.

VIDEO ALERT: Additional audio and video resources, including excerpts from an interview with Dr. Clifford Jack Jr. are available on the Mayo Clinic News Blog(http://newsblog.mayoclinic.org/2012/05/23/mayo-researcher-receives-two-major-honors/feed/).

MetLife Foundation Award:

Dr. Jack was selected as one of two 2012 recipients of the MetLife Foundation Award for Medical Research in Alzheimer's Disease. Since 1986, this Foundation has presented awards to scientists who make significant contributions to the understanding of Alzheimer's. The program's goal is recognizing the importance of basic research with an emphasis on providing scientists the opportunity to pursue ideas. He received the award May 15 in New York.

International Society for Magnetic Resonance in Medicine Gold Medal Award:

Dr. Jack recently accepted another award -- the 2012 ISMRM Gold Medal Award -- in recognition of his major research contributions to the field of magnetic resonance. Society President Debiao Li, Ph.D., presented the award to Dr. Jack at the organization's annual meeting in Melbourne, Australia, on May 7.

ISMRM is a multidisciplinary nonprofit association that promotes innovation, development, and application of magnetic resonance techniques in medicine and biology throughout the world.

"These are huge honors and pay tribute to Dr. Jack's outstanding impact in this field," says Ron Petersen, M.D., Ph.D., head of Mayo Clinic's Alzheimer's Center. "His work has had a significant impact on the recent revisions of the criteria for Alzheimer's disease."

Dr. Jack is a neurorad
'/>"/>

Contact: Robert Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Mayo Clinic urologists present findings at American Urological Association Annual Meeting
2. Canada should significantly increase its funding of randomized clinical trials
3. Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
4. Mayo Clinic: Standard heart disease risk tools underrate danger in rheumatoid arthritis
5. Experts call for clinical trials to test non-skeletal benefits of vitamin D
6. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
7. Mayo Clinic researchers discover biomarkers for prostate cancer detection, recurrence
8. Automated insulin dosage titration system demonstrates positive clinical study results
9. Mayo Clinic: Exhaustion renders immune cells less effective in cancer treatment
10. Analysis Finds Clinical Trials Often Small, of Poor Quality
11. URMC clinical trial tests new regimen for hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 Merrill ... of technology-enabled services for the financial, legal, healthcare ... virtual data room business, Merrill DataSite, has been ... presented by GrowthBusiness at the M&A Awards 2014 ... the achievements of entrepreneurs, management teams, advisors and ...
(Date:7/25/2014)... Ticket Down is a reliable source for ... at California Memorial Stadium. With the post-World Cup emotions ... organizers of the 2014 Guinness International Champions Cup have brought ... With teams representing La Liga, English Premier League, Serie A, ... best football players from around the world to 12 American ...
(Date:7/25/2014)... July 25, 2014(BRONX, NY)A study involving nearly 27,000 older ... 10 met criteria for pre-dementia based on a simple ... they have cognitive complaints. People who tested positive for ... dementia within 12 years. The study, led by scientists ... Yeshiva University and Montefiore Medical Center , was ...
(Date:7/25/2014)... As thousands of transvaginal mesh lawsuits ... Liebhard LLP notes that the Food & Drug Administration ... group, Public Citizen, to order a global recall of ... 1, 2014, and released to the public last week, ... ban on the marketing of all surgical mesh devices ...
(Date:7/25/2014)... drug can protect vulnerable neurons and reduce motor ... researchers at Emory University School of Medicine have ... Journal of Parkinson,s Disease . , The ... reach the brain at sufficient levels and have ... an insulin shot. Previous studies of XPro1595 in ...
Breaking Medicine News(10 mins):Health News:Merrill DataSite Recognized as “Technology Provider of the Year” by GrowthBusiness at the M&A Awards 2014 Event 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:Slow walking speed and memory complaints can predict dementia 2Health News:Slow walking speed and memory complaints can predict dementia 3Health News:Slow walking speed and memory complaints can predict dementia 4Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 4Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2
... in just one state, but a resurgence could occur, CDC ... As the H1N1 swine flu outbreak eases to a point ... health officials are still urging Americans to get their swine ... Week," Kathleen Sebelius, Secretary of the U.S. Department of Health ...
... , , , , MINNEAPOLIS, Jan. ... National Courage Award . Since 1980, Minnesota-based Courage ... an individual,s contributions to the health, welfare and rehabilitation of ... winners include: Max Cleland, Justin Dart Jr., Sen. Bob Dole, ...
... DHA boosted memory of Alzheimer,s patients in study , ... nutrients might help improve memory in Alzheimer,s patients by stimulating ... shows. , Uridine, choline and the omega-3 fatty acid DHA ... molecules that make up brain cell membranes, which form synapses. ...
... LAVAL, QC, Jan. 8 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... draw down of $1 million under its standby equity distribution (SEDA) ... Labopharm issued 482,165 of its common shares to YA at a ... (All currency figures are in Canadian dollars.) , In accordance with ...
... ... at 32nd annual San Antonio Breast Cancer Symposium , ... Los Angeles, CA (PRWEB) January ... announced that multiple clinical studies of the chemotherapy agent ABRAXANE® for Injectable Suspension ...
... low level X-rays, , FRIDAY, Jan. 8 (HealthDay News) ... airline flight approaching Detroit, officials have announced plans to increase ... some travelers wondering about the health effects of these devices. ... expose passengers to excess levels of radiation? Experts say no. ...
Cached Medicine News:Health News:As Swine Flu Ebbs, Officials Stress Importance of Vaccine 2Health News:As Swine Flu Ebbs, Officials Stress Importance of Vaccine 3Health News:Courage Center Seeks Nominations for 2010 National Courage Award 2Health News:Labopharm settles $1 million draw down under standby equity distribution agreement 2Health News:Labopharm settles $1 million draw down under standby equity distribution agreement 3Health News:Abraxis Provides Overview Of ABRAXANE Study 2Health News:Abraxis Provides Overview Of ABRAXANE Study 3Health News:Airport Full Body Scanners Pose No Health Threat: Experts 2Health News:Airport Full Body Scanners Pose No Health Threat: Experts 3
(Date:7/24/2014)... HILDEN , Deutschland, und ... , ... ermöglicht QIAGEN die Entwicklung von ... Genpanels, für Blutkrebs  Neuer Test ... Patienten mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen ...
(Date:7/24/2014)... Ohio, July 24, 2014  Mettler-Toledo International Inc. (NYSE: ... for 2014.  Provided below are the highlights: ... the quarter compared with the prior year. Reported sales ... , Net earnings per diluted share as reported ... quarter of 2013. Adjusted EPS was $2.57, an increase ...
(Date:7/24/2014)... 24, 2014 IGI Laboratories, Inc. (NYSE MKT: ... specialty generic pharmaceutical company, today announced it has accepted  ... Directors.  Mr. Finio has accepted a senior level finance ... of his acceptance of his new position, Mr. Finio ... Director for IGI Laboratories, Inc.  The effective date of ...
Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 2Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 3Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 4Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 5Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 6Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 7Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 8Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 9Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 10Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 11Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 12Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 13Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 14Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 15Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 16Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 17Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 18Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 19Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 20Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 2Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 3Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 4Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 5Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 6Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 7Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 8
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: